1
--------------------------------
OMB APPROVAL
--------------------------------
UNITED STATES OMB Number: 3235-0058
SECURITIES AND EXCHANGE COMMISSION Expires: January 31, 2002
Washington, D.C. 20549 Estimated average burden
hours per response . . . . 2.50
--------------------------------
FORM 12B-25
-----------------------------
SEC FILE NUMBER
000-28288
-----------------------------
NOTIFICATION OF LATE FILING
-----------------------------
CUSIP NUMBER
278849-10-4
-----------------------------
(Check One):/X/Form 10-K / /Form 20-F / /Form 11-K / /Form 10-Q / /Form N-SAR
For Period Ended: December 31, 2000
------------------------------------------
[ ] Transition Report on Form 10-K [ ] Transition Report on
Form 20-F [ ] Transition Report on Form 11-K [ ] Transition
Report on Form 10-Q [ ] Transition Report on Form N-SAR For
the Transition Period Ended:
------------------------------
- -------------------------------------------------------------------------------
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
VERIFIED ANY INFORMATION CONTAINED HEREIN.
- -------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
- -------------------------------------------------------------------------------
PART I -- REGISTRANT INFORMATION
- -------------------------------------------------------------------------------
Full Name of Registrant
ECLIPSE SURGICAL TECHNOLOGIES, INC.
- -------------------------------------------------------------------------------
Former Name if Applicable
N/A
- -------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
1049 Kiel Court
- -------------------------------------------------------------------------------
City, State and Zip Code
Sunnyvale, CA 94089
PART II -- RULES 12B-25(B) AND (C)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
/X/ (b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or
portion thereof, will be filed on or before the fifteenth
calendar day following the prescribed due date; or the
subject quarterly report of transition report on Form 10-Q,
or portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III -- NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
As previously announced, the company has recently significantly cut back the
number of people it employs, including in its finance group. Due to these
cutbacks and the need to expend time and energy pursuing financing options
for the company, the company cannot file its Annual Report on Form 10-K \
within the prescribed time period.
(ATTACH EXTRA SHEETS IF NEEDED)
SEC 1344 (6/94)
POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF
INFORMATION CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS
THE FORM DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER.
2
PART IV -- OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
Ian A. Johnston (408) 548-2137
----------------------------- --------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If answer
is no, identify report(s). Yes /x/ No / /
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected
by the earnings statements to be included in the subject report or portion
thereof?
Yes / / No /x/
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
- -------------------------------------------------------------------------------
ECLIPSE SURGICAL TECHNOLOGIES, INC.
- -------------------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date March 30, 2001 By /s/ Ian A. Johnston
-------------------------------------- ---------------------------------
Vice President of Finance and
Treasurer
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representa- tive. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
- ---------------------- ATTENTION --------------------------
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
- ---------------------------------------------------------------------------